$3.25
3.40% today
Nasdaq, Feb 28, 04:25 pm CET
ISIN
US45779A8466
Symbol
NSPR

InspireMD Inc Stock price

$3.36
+0.66 24.44% 1M
+0.51 17.89% 6M
+0.73 27.76% YTD
+0.63 23.08% 1Y
+0.69 25.84% 3Y
-10.15 75.12% 5Y
-3,937,496.64 100.00% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.00 0.00%
ISIN
US45779A8466
Symbol
NSPR
Sector

Key metrics

Market capitalization $87.64m
Enterprise Value $48.47m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 7.11
P/S ratio (TTM) P/S ratio 12.85
P/B ratio (TTM) P/B ratio 2.09
Revenue growth (TTM) Revenue growth 24.70%
Revenue (TTM) Revenue $6.82m
EBIT (operating result TTM) EBIT $-29.94m
Free Cash Flow (TTM) Free Cash Flow $-20.60m
Cash position $40.40m
EPS (TTM) EPS $-0.84
P/S forward 12.71
EV/Sales forward 7.03
Short interest 1.02%
Show more

Is InspireMD Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

InspireMD Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

Buy
100%

Financial data from InspireMD Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
6.82 6.82
25% 25%
100%
- Direct Costs 5.28 5.28
33% 33%
77%
1.54 1.54
3% 3%
23%
- Selling and Administrative Expenses 19 19
42% 42%
282%
- Research and Development Expense 12 12
51% 51%
176%
-30 -30
48% 48%
-435%
- Depreciation and Amortization 0.27 0.27
17% 17%
4%
EBIT (Operating Income) EBIT -30 -30
48% 48%
-439%
Net Profit -28 -28
46% 46%
-414%

In millions USD.

Don't miss a Thing! We will send you all news about InspireMD Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

InspireMD Inc Stock News

Neutral
GlobeNewsWire
2 days ago
MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced that it will release its fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025. In conjunction with the release, InspireMD will host a conference call an...
Neutral
GlobeNewsWire
3 days ago
MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD's Board of Directors approved inducement grants to six new non-executive employees in the aggregate amount of 138,442 shares of restricted stock outside of InspireMD's 2021 Equity C...
Neutral
GlobeNewsWire
15 days ago
TOLEDO, Ohio and MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime Carotid Stent System for the prevention of stroke related to carotid stenosis, and NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, today announced that, pursuant to a previously announced strategic outsourci...
More InspireMD Inc News

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Head office United States
CEO Marvin Slosman
Employees 66
Founded 2005
Website www.inspiremd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today